Publications

Found 163 results
Filters: Author is S Muyldermans  [Clear All Filters]
2013
Muyldermans, S., "Nanobodies: natural single-domain antibodies.", Annu Rev Biochem, vol. 82, pp. 775-97, 2013.
De Genst, E., P-H. Chan, E. Pardon, S-T. D. Hsu, J. R. Kumita, J. Christodoulou, L. Menzer, D. Y. Chirgadze, C. V. Robinson, S. Muyldermans, et al., "A nanobody binding to non-amyloidogenic regions of the protein human lysozyme enhances partial unfolding but inhibits amyloid fibril formation.", J Phys Chem B, vol. 117, issue 42, pp. 13245-58, 2013 Oct 24.
Nguyen-Duc, T., E. Peeters, S. Muyldermans, D. Charlier, and G. Hassanzadeh-Ghassabeh, "Nanobody(R)-based chromatin immunoprecipitation/micro-array analysis for genome-wide identification of transcription factor DNA binding sites.", Nucleic Acids Res, vol. 41, issue 5, pp. e59, 2013 Mar 1.
Butler, J. E., N. Wertz, X-Z. Sun, J. K. Lunney, and S. Muyldermans, "Resolution of an immunodiagnostic dilemma: heavy chain chimeric antibodies for species in which plasmocytomas are unknown.", Mol Immunol, vol. 53, issue 1-2, pp. 140-8, 2013 Jan.
Fleetwood, F., N. Devoogdt, M. Pellis, U. Wernery, S. Muyldermans, S. Ståhl, and J. Löfblom, "Surface display of a single-domain antibody library on Gram-positive bacteria.", Cell Mol Life Sci, vol. 70, issue 6, pp. 1081-93, 2013 Mar.
Xavier, C., I. Vaneycken, M. D'huyvetter, J. Heemskerk, M. Keyaerts, C. Vincke, N. Devoogdt, S. Muyldermans, T. Lahoutte, and V. Caveliers, "Synthesis, preclinical validation, dosimetry, and toxicity of 68Ga-NOTA-anti-HER2 Nanobodies for iPET imaging of HER2 receptor expression in cancer.", J Nucl Med, vol. 54, issue 5, pp. 776-84, 2013 May.
Habib, I., D. Smolarek, C. Hattab, M. Grodecka, G. Hassanzadeh-Ghassabeh, S. Muyldermans, S. Sagan, C. Gutiérrez, S. Laperche, C. Le-Van-Kim, et al., "V(H)H (nanobody) directed against human glycophorin A: a tool for autologous red cell agglutination assays.", Anal Biochem, vol. 438, issue 1, pp. 82-9, 2013 Jul 1.
2012
Pellis, M., S. Muyldermans, and C. Vincke, "Bacterial two hybrid: a versatile one-step intracellular selection method.", Methods Mol Biol, vol. 911, pp. 135-50, 2012.
Abbady, A. Q., A. Al-Daoude, A. Al-Mariri, M. Zarkawi, and S. Muyldermans, "Chaperonin GroEL a Brucella immunodominant antigen identified using Nanobody and MALDI-TOF-MS technologies.", Vet Immunol Immunopathol, vol. 146, issue 3-4, pp. 254-63, 2012 May 15.
D'huyvetter, M., A. Aerts, C. Xavier, I. Vaneycken, N. Devoogdt, M. Gijs, N. Impens, S. Baatout, B. Ponsard, S. Muyldermans, et al., "Development of 177Lu-nanobodies for radioimmunotherapy of HER2-positive breast cancer: evaluation of different bifunctional chelators.", Contrast Media Mol Imaging, vol. 7, issue 2, pp. 254-64, 2012 Mar-Apr.
Govaert, J., M. Pellis, N. Deschacht, C. Vincke, K. Conrath, S. Muyldermans, and D. Saerens, "Dual beneficial effect of interloop disulfide bond for single domain antibody fragments.", J Biol Chem, vol. 287, issue 3, pp. 1970-9, 2012 Jan 13.
Behdani, M., S. Zeinali, H. Khanahmad, M. Karimipour, N. Asadzadeh, K. Azadmanesh, A. Khabiri, S. Schoonooghe, M. Habibi Anbouhi, G. Hassanzadeh-Ghassabeh, et al., "Generation and characterization of a functional Nanobody against the vascular endothelial growth factor receptor-2; angiogenesis cell receptor.", Mol Immunol, vol. 50, issue 1-2, pp. 35-41, 2012 Feb.
Zhu, J., J. Declercq, B. Roucourt, G. H. Ghassabeh, S. Meulemans, J. Kinne, G. David, A. J. M. Vermorken, W. J. M. Van de Ven, I. Lindberg, et al., "Generation and characterization of non-competitive furin-inhibiting nanobodies.", Biochem J, vol. 448, issue 1, pp. 73-82, 2012 Nov 15.
Vincke, C., C. Gutiérrez, U. Wernery, N. Devoogdt, G. Hassanzadeh-Ghassabeh, and S. Muyldermans, "Generation of single domain antibody fragments derived from camelids and generation of manifold constructs.", Methods Mol Biol, vol. 907, pp. 145-76, 2012.
Vincke, C., and S. Muyldermans, "Introduction to heavy chain antibodies and derived Nanobodies.", Methods Mol Biol, vol. 911, pp. 15-26, 2012.
Broisat, A., S. Hernot, J. Toczek, J. De Vos, L. M. Riou, S. Martin, M. Ahmadi, N. Thielens, U. Wernery, V. Caveliers, et al., "Nanobodies targeting mouse/human VCAM1 for the nuclear imaging of atherosclerotic lesions.", Circ Res, vol. 110, issue 7, pp. 927-37, 2012 Mar 30.
Duc, T. Nguyen, G. Hassanzadeh-Ghassabeh, D. Saerens, E. Peeters, D. Charlier, and S. Muyldermans, "Nanobody-based chromatin immunoprecipitation.", Methods Mol Biol, vol. 911, pp. 491-505, 2012.
Hernot, S., S. Unnikrishnan, Z. Du, T. Shevchenko, B. Cosyns, A. Broisat, J. Toczek, V. Caveliers, S. Muyldermans, T. Lahoutte, et al., "Nanobody-coupled microbubbles as novel molecular tracer.", J Control Release, vol. 158, issue 2, pp. 346-53, 2012 Mar 10.
Hmila, I., B. Cosyns, H. Tounsi, B. Roosens, V. Caveliers, R. Ben Abderrazek, S. Boubaker, S. Muyldermans, M. El Ayeb, B. Bouhaouala-Zahar, et al., "Pre-clinical studies of toxin-specific nanobodies: evidence of in vivo efficacy to prevent fatal disturbances provoked by scorpion envenoming.", Toxicol Appl Pharmacol, vol. 264, issue 2, pp. 222-31, 2012 Oct 15.
Caljon, G., V. Caveliers, T. Lahoutte, B. Stijlemans, G. H. Ghassabeh, J. Van Den Abbeele, I. Smolders, P. De Baetselier, Y. Michotte, S. Muyldermans, et al., "Using microdialysis to analyse the passage of monovalent nanobodies through the blood-brain barrier.", Br J Pharmacol, vol. 165, issue 7, pp. 2341-53, 2012 Apr.

Pages